提供学术论文选刊润色服务
医学
医学
Paper Review Records
全部论文审稿周期
19 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
175
天
A Dose‐Escalation Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of HP501 in Male Chinese Gout Patients with Hyperuricemia
作者Longxia Chen; Ruilin Ding; Yuanwei Chen; Xinghai Li; Tengqiong Xiong; Hong Chen; Xiaojing Hu; Yi Zhou; Feng Jiang; Qing Peng
作者单位1. Institute of Drug Clinical Trial/GCP Center The Affiliated Hospital of Southwest Medical University Luzhou China; 2. Hinova Pharmaceuticals Inc. Chengdu China; 3. Department of Cardiology The Affiliated Hospital of Southwest Medical University Luzhou China
241
天
A First‐in‐Japanese Phase 1, Double‐Blind, Placebo‐Controlled, Parallel‐Cohort Study of Sefaxersen, an Antisense Oligonucleotide Targeting Complement Factor B, in Healthy Participants
作者Takakazu Sato; Hiroyuki Fukase; Takaaki Ishida; Arisa Karasawa
作者单位1. Chugai Pharmaceutical Co., Ltd. Tokyo Japan; 2. Clinical Research Hospital Tokyo Japan
277
天
Pharmacokinetic and Pharmacodynamic Bio‐Similarity of ADL‐018 to Innovator Omalizumab: A Randomized Study in Healthy Adults
作者Sunil Soitawala; Hiren Prajapati; Hiren Mehta; Pawan Kumar Singh
作者单位1. Clinical Research Department Veeda Clinical Research Ltd. Mehsana Gujarat India; 2. Clinical Research Department Veeda Clinical Research Ltd. Ahmedabad Gujarat India; 3. Clinical Affairs/Biometrics Department Veeda Clinical Research Ltd. Ahmedabad Gujarat India; 4. Kashiv Biosciences, LLC Ahmedabad Gujarat India
126
天
An Open‐Label Study Investigating the 5‐HT 2A Receptor Occupancy of Remlifanserin (ACP‐204) With the PET Radioligand [ 18 F]Altanserin in Healthy Male Participants
作者Ethan S. Burstein; Christine Sandiego; Brian Raether; Xiaoshu Feng; Bryan Dirks; Mona Darwish; Peter Zhang; David S. Russell; Eugenii A. Rabiner; Sanjeev Pathak
作者单位1. Acadia Pharmaceuticals Inc. San Diego CA USA; 2. Perceptive Discovery New Haven CT USA; 3. Acadia Pharmaceuticals Inc. Princeton NJ USA; 4. Perceptive Discovery London UK
102
天
A Phase 1, Single‐Center, Randomized, Double‐Blind, Placebo‐Controlled, Multiple‐Dose Escalation Study for the Evaluation of the Safety, Tolerability, and Pharmacokinetics of Recombinant Human Plasma Gelsolin (rhu‐pGSN) Following Intravenous Administration to Healthy Volunteers
作者Yao Liu; Susan L. Levinson; Edward Kowalik; Jeremy Pronchik; Lester Kobzik; Mark J. DiNubile
作者单位1. BioAegis Therapeutics North Brunswick NJ USA
133
天
Comparative Bioavailability of a Fixed‐Dose Combination of Etoricoxib and Betamethasone in Healthy Volunteers
作者Lourdes Garza‐Ocañas; Christian T. Badillo‐Castañeda; Sandra L. Montoya‐Eguía; María T. Zanatta‐Calderón; Julia D. Torres‐Garza; Pedro Lennon Sáenz‐ Chávez; Kevin F. Rios‐Brito; Pablo E. Morales‐Hernandez; Seydhel C. Reyes‐Granados; Jorge González‐Canudas
作者单位1. Pharmacology and Toxicology Department Autonomous University of Nuevo Leon Monterrey Mexico; 2. Research and Development Department Laboratorios Silanes, S.A. de C.V. Mexico City Mexico; 3. Mexican Social Security Institute (IMSS) Centro Médico Nacional Siglo XXI Mexico City Mexico
145
天
Bioequivalence of two rabeprazole formulations and pharmacokinetic variability by CYP2C19 genotype and sex in healthy Korean participants: A four‐period replicated crossover study
作者Nakyong Lee; Joo‐Youn Cho; Byungwook Kim
作者单位1. Department of Clinical Medical Sciences Seoul National University College of Medicine Seoul Republic of Korea; 2. Department of Biomedical Sciences Seoul National University College of Medicine Seoul Republic of Korea; 3. Department of Clinical Pharmacology and Therapeutics Seoul National University College of Medicine and Hospital Seoul Republic of Korea; 4. Kidney Research Institute Seoul National University Medical Research Center Seoul Republic of Korea; 5. Department of Pharmacology Kangwon National University School of Medicine Chuncheon Republic of Korea
296
天
Assessment of Pharmacokinetic Interaction and Clinical Efficacy of Clopidogrel Co‐administered with Ilaprazole
作者Damodharan N; Priyadharshini A; Vijayakumar T M; Rajesh N A
作者单位1. Department of Pharmaceutics SRM College of Pharmacy SRM Institute of Science and Technology Kattankulathur Tamil Nadu India; 2. Department of Pharmacy Practice SRM College of Pharmacy SRM Institute of Science and Technology Kattankulathur Tamil Nadu India; 3. Department of Medical Gastroenterology SRM Medical College Hospital and Research Centre SRM Institute of Science and Technology Kattankulathur Tamil Nadu India
103
天
Bioequivalence Study of Two Ibuprofen Arginine Formulations in Healthy Chinese Subjects Under Fed Conditions
作者Yiyang Ying; Chunqi Huang; Li Xu; Yi Wu; Shufan Cai; Lijun Ye; Xiangxin Huang; Lin Wang; Ying Wang
作者单位1. The First Clinical Medical College Zhejiang Chinese Medical University Hangzhou Zhejiang Province China; 2. Department of Laboratory Medicine The Second Affiliated Hospital of Zhejiang Chinese Medical University, Xinhua Hospital of Zhejiang Province Hangzhou Zhejiang China; 3. School of Pharmacy Hangzhou Normal University Hangzhou Zhejiang China; 4. Clinical Research Center Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University Hangzhou China; 5. Zhejiang Key Laboratory of Zero Magnetic Medicine Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University Hangzhou China
214
天
Exposure–Response Relationship of Dostarlimab in Primary Advanced/Recurrent Endometrial Cancer: Results From Interim Analysis 2 of Part 1 of the RUBY Trial
作者Mita Kuchimanchi; Trine Lembrecht Jørgensen; Eva Hanze; Angela Jain; Oskar Alskär; Oleksandr Zub; Mark S. Shahin; Anthoula Koliadi; Bhavana Pothuri; Thomas Krivak; Mikalai Pishchyk; Yakir Segev; Floor J. Backes; Christine Gennigens; Sara Bouberhan; Stefan Zajic; Murad Melhem; Joseph Buscema
作者单位1. GSK Waltham MA USA; 2. Department of Oncology Odense University Hospital Odense Denmark; 3. qPharmetra Uppsala Sweden; 4. Fox Chase Cancer Center Philadelphia PA USA; 5. Chernihiv Medical Center of Modern Oncology Chernihiv Regional Council Chernihiv Ukraine; 6. Division of Gynecologic Oncology Penn State Hershey Medical Center Hershey PA USA; 7. Department of Gynecologic Oncology Uppsala University Hospital Uppsala Sweden; 8. Nordic Society of Gynaecological Oncology (NSGO) Clinical Trial Unit Copenhagen Denmark; 9. Departments of Obstetrics and Gynecology and Medicine Division of Gynecologic Oncology NYU Langone Health New York NY USA; 10. GOG Foundation Philadelphia PA USA; 11. Division of Gynecologic Oncology The Western Pennsylvania Hospital Pittsburgh PA USA; 12. Grodno Regional Clinical Hospital Grodno Belarus; 13. Carmel Medical Center Technion‐Israel Institute of Technology Haifa Israel; 14. Division of Gynecologic Oncology Ohio State University Columbus OH USA; 15. Department of Medical Oncology CHU of Liège Liège Belgium; 16. Belgium and Luxembourg Gynaecological Oncology Group (BGOG) Leuven Belgium; 17. Massachusetts General Hospital Boston MA USA; 18. Affiliation at time of study GSK Collegeville PA USA; 19. TMC Healthcare Cancer Center Tucson AZ USA
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿96.4 天
中位数77 天